DcpS, a general modulator of cap-binding protein-dependent processes?

RNA Biology

Volumn 5, Issue 4, 2008, Pages 216-219

  Bail, Sophie ^a   Kiledjian, Megerditch ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b Department of Cell Biology and Neuroscience ^*  (United States)

Author keywords

DcpS; Decapping; mRNA decay; mRNA translation; mRNA transport; Pre mRNA splicing

Indexed keywords

CAP BINDING PROTEIN; ENZYME; ENZYME DCPS; MESSENGER RNA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; BIOGENESIS; CATALYSIS; CELL COMPARTMENTALIZATION; CELL FUNCTION; CONCENTRATION (PARAMETERS); CYTOPLASM; ENVIRONMENTAL STRESS; ENZYME ACTIVITY; GENE CONTROL; HUMAN; HYDROLYSIS; INTRON; MAMMAL CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS; REVIEW; RNA METABOLISM; RNA SPLICING; RNA TRANSLATION; YEAST;

MAMMALIA;

EID: 57349121979     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.7161     Document Type: Review

References (49)

1. Rodgers ND, Wang Z, Kiledjian M. Regulated alpha-globin mRNA decay is a cytoplasmic event proceeding through 3′-to-5′ exosome-dependent decapping. RNA 2002; 8:1526-37.
2. Wang Z, Kiledjian M. Functional Link between the Mammalian Exosome and mRNA Decapping. Cell 2001; 107:751-62.
3. Liu H, Rodgers ND, Jiao X, Kiledjian M. The scavenger mRNA decapping enzyme DcpS is a member of the HIT family of pyrophosphatases. EMBO J 2002; 21:4699-708.
4. Dunckley T, Parker R. The DCP2 protein is required for mRNA decapping in Saccharomyces cerevisiae and contains a functional MutT motif. EMBO J 1999; 18:5411-22.
5. Lykke-Andersen J. Identification of a human decapping complex associated with hUpf proteins in nonsense-mediated decay. Mol Cell Biol 2002; 22:8114-21.
6. van Dijk E, Cougot N, Meyer S, Babajko S, Wahle E, Seraphin B. Human Dcp2: a catalytically active mRNA decapping enzyme located in specific cytoplasmic structures. EMBO J 2002; 21:6915-24.
7. Wang Z, Jiao X, Carr-Schmid A, Kiledjian M. The hDcp2 protein is a mammalian mRNA decapping enzyme. Proc Natl Acad Sci USA 2002; 99:12663-8.
8. van Dijk E, Le Hir H, Seraphin B. DcpS can act in the 5′-3′ mRNA decay pathway in addition to the 3′-5′ pathway. Proc Natl Acad Sci USA 2003; 100:12081-6.
9. Seraphin B. The HIT protein family: a new family of proteins present in prokaryotes, yeast and mammals. DNA Seq 1992; 3:177-9.
10. Lima CD, Klein MG, Hendrickson WA. Structure-based analysis of catalysis and substrate definition in the HIT protein family. Science 1997; 278:286-90.
11. Chen N, Walsh MA, Liu Y, Parker R, Song H. Crystal structures of human DcpS in ligand-free and m7GDP-bound forms suggest a dynamic mechanism for scavenger mRNA decapping. J Mol Biol 2005; 347:707-18.
12. Han GW, Schwarzenbacher R, McMullan D, Abdubek P, Ambing E, Axelrod H, et al. Crystal structure of an Apo mRNA decapping enzyme (DcpS) from Mouse at 1.83 A resolution. Proteins 2005; 60:797-802.
13. Gu M, Fabrega C, Liu SW, Liu H, Kiledjian M, Lima CD. Insights into the structure, mechanism and regulation of scavenger mRNA decapping activity. Mol Cell 2004; 14:67-80.
14. Liu SW, Rajagopal V, Patel SS, Kiledjian M. Mechanistic and kinetic analysis of the DcpS scavenger decapping enzyme. J Biol Chem 2008; 283:16427-36.
15. 7GpppG and m3(2,2,7)GpppG decapping: activities in Ascaris embryos and characterization of C. elegans scavenger DcpS. RNA 2004; 10:1609-24.
16. Salehi Z, Geffers L, Vilela C, Birkenhager R, Ptushkina M, Berthelot K, et al. A nuclear protein in Schizosaccharomyces pombe with homology to the human tumour suppressor Fhit has decapping activity. Mol Microbiol 2002; 46:49-62.
17. Cougot N, Babajko S, Seraphin B. Cytoplasmic foci are sites of mRNA decay in human cells. J Cell Biol 2004; 165:31-40.
18. Liu SW, Jiao X, Liu H, Gu M, Lima CD, Kiledjian M. Functional analysis of mRNA scavenger decapping enzymes. RNA 2004; 10:1412-22.
19. Shen V, Liu H, Liu SW, Jiao X, Kiledjian M. DcpS scavenger decapping enzyme can modulate pre-mRNA splicing. RNA 2008; 14:1132-42.
20. Edery I, Sonenberg N. Cap-dependent RNA splicing in a HeLa nuclear extract. Proc Natl Acad Sci USA 1985; 82:7590-4.
21. Furuichi Y, LaFiandra A, Shatkin AJ. 5′-Terminal structure and mRNA stability. Nature 1977; 266:235-9.
22. Hamm J, Mattaj IW. Monomethylated cap structures facilitate RNA export from the nucleus. Cell 1990; 63:109-18.
23. Izaurralde E, Lewis J, McGuigan C, Jankowska M, Darzynkiewicz E, Mattaj IW. A nuclear cap binding protein complex involved in pre-mRNA splicing. Cell 1994; 78:657-68.
24. Konarska MM, Padgett RA, Sharp PA. Recognition of cap structure in splicing in vitro of mRNA precursors. Cell 1984; 38:731-6.
25. Muthukrishnan S, Both GW, Furuichi Y, Shatkin AJ. 5′-Terminal 7-methylguanosine in eukaryotic mRNA is required for translation. Nature 1975; 255:33-7.
26. Lewis JD, Izaurralde E. The role of the cap structure in RNA processing and nuclear export. Eur J Biochem 1997; 247:461-9.
27. Gingras AC, Raught B, Sonenberg N. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 1999; 68:913-63.
28. Liu H, Kiledjian M. Scavenger decapping activity facilitates 5′ to 3′ mRNA decay. Mol Cell Biol 2005; 25:9764-72.
29. Hsu CL, Stevens A. Yeast cells lacking 5′→3′ exoribonuclease 1 contain mRNA species that are poly(A) deficient and partially lack the 5′ cap structure. Mol Cell Biol 1993; 13:4826-35.
30. Johnson AW. Rat1p and Xrn1p are functionally interchangeable exoribonucleases that are restricted to and required in the nucleus and cytoplasm, respectively. Mol Cell Biol 1997; 17:6122-30.
31. Meyer S, Temme C, Wahle E. Messenger RNA turnover in eukaryotes: pathways and enzymes. Crit Rev Biochem Mol Biol 2004; 39:197-216.
32. 7GpppG binding to the nuclear cap-binding protein complex. Nat Struct Biol 2002; 9:912-7.
33. Berget SM. Exon recognition in vertebrate splicing. J Biol Chem 1995; 270:2411-4.
34. Lewis JD, Izaurralde E, Jarmolowski A, McGuigan C, Mattaj IW. A nuclear cap-binding complex facilitates association of U1 snRNP with the cap-proximal 5′ splice site. Genes Dev 1996; 10:1683-98.
35. Inoue K, Ohno M, Sakamoto H, Shimura Y. Effect of th cap structure on pre-mRNA splicing in Xenopus oocyte nuclei. Genes Dev 1989; 3:1472-9.
36. Davuluri RV, Grosse I, Zhang MQ. Computational identification of promoters and first exons in the human genome. Nat Genet 2001; 29:412-7.
37. Lejeune F, Maquat LE. Mechanistic links between nonsense-mediated mRNA decay and pre-mRNA splicing in mammalian cells. Curr Opin Cell Biol 2005; 17:309-15.
38. Chang YF, Imam JS, Wilkinson MF. The nonsense-mediated decay RNA surveillance pathway. Annu Rev Biochem 2007; 76:51-74.
39. Flaherty SM, Fortes P, Izaurralde E, Mattaj IW, Gilmartin GM. Participation of the nuclear cap binding complex in pre-mRNA 3′ processing. Proc Natl Acad Sci USA 1997; 94:11893-8.
40. Gasch AP, Spellman PT, Kao CM, Carmel-Harel O, Eisen MB, Storz G, et al. Genomic expression programs in the response of yeast cells to environmental changes. Mol Biol Cell 2000; 11:4241-57.
41. Kwasnicka DA, Krakowiak A, Thacker C, Brenner C, Vincent SR. Coordinate expression of NADPH-dependent flavin reductase, Fre-1 and Hint-related 7meGMP-directed hydrolase, DCS-1. J Biol Chem 2003; 278:39051-8.
42. 7GpppX pyrophosphatase activity of Dcs1 modulates nutrient-induced responses in yeast. Nucleic Acids Res 2004; 32:3590-600.
43. Daneholt B. A look at messenger RNP moving through the nuclear pore. Cell 1997; 88:585-8.
44. Jarmolowski A, Boelens WC, Izaurralde E, Mattaj IW. Nuclear export of different classes of RNA is mediated by specific factors. J Cell Biol 1994; 124:627-35.
45. Visa N, Izaurralde E, Ferreira J, Daneholt B, Mattaj IW. A nuclear cap-binding complex binds Balbiani ring pre-mRNA cotranscriptionally and accompanies the ribonucleoprotein particle during nuclear export. J Cell Biol 1996; 133:5-14.
46. Niedzwiecka A, Stepinski J, Antosiewicz JM, Darzynkiewicz E, Stolarski R. Biophysical approach to studies of cap-eIF4E interaction by synthetic cap analogs. Methods Enzymol 2007; 430:209-45.
47. Darzynkiewicz E, Ekiel I, Lassota P, Tahara SM. Inhibition of eukaryotic translation by analogues of messenger RNA 5′-cap: chemical and biological consequences of 5′-phosphate modifications of 7-methylguanosine 5′-monophosphate. Biochemistry 1987; 26:4372-80.
48. Darzynkiewicz E, Stepinski J, Ekiel I, Goyer C, Sonenberg N, Temeriusz A, et al. Inhibition of eukaryotic translation by nucleoside 5′- monophosphate analogues of mRNA 5′-cap: changes in N7 substituent affect analogue activity. Biochemistry 1989; 28:4771-8.
49. Kowalska J, Lewdorowicz M, Zuberek J, Grudzien-Nogalska E, Bojarska E, Stepinski J, et al. Synthesis and characterization of mRNA cap analogs containing phosphorothioate substitutions that bind tightly to eIF4E and are resistant to the decapping pyrophosphatase DcpS. RNA 2008; 14:1119-31.